Nicotine replacement therapy
Pre-clinicalUNKNOWN 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Aug 1, 2015 → Jul 1, 2017
NCT ID
NCT02470923About Nicotine replacement therapy
Nicotine replacement therapy is a pre-clinical stage product being developed by Novartis for Smoking Cessation. The current trial status is unknown. This product is registered under clinical trial identifier NCT02470923. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02470923 | Pre-clinical | UNKNOWN |
Competing Products
20 competing products in Smoking Cessation